Home › EMSLIMITED › Filing
🔔 Get instant alerts when EMSLIMITED files quarterly results on BSE Start free trial →
EMS Limited (EMSLIMITED)

Analysts/Institutional Investor Meet/Con. Call Updates

Filed: 17 Nov 2026, 12:44 IST Exchange: NSE Category: Financial Results — Earnings Call Transcript
AI summary - Q2 FY27 standalone revenue Rs. 160.89 Cr (+30%), EBITDA Rs. 35.82 Cr (+50%), PAT Rs. 22.92 Cr (+50%) - Order book Rs. 3,152 Cr as of Sep 30, 2026; Rs. 900 Cr new orders pending execution - Revenue execution expected at ~40% of order book (~Rs. 1,200 Cr) in FY27 - EBITDA margin Q2 at 22.26%, PAT margin 14.25%; target ~25% EBITDA margin by Q4 FY27 - No major CAPEX planned; growth driven by government CAPEX projects - Collections normalized in UP; some delays in Uttarakhand due to funding portal changes - Expect 20% CAGR revenue growth over next 2-3 years, recovering from FY26 monsoon impact - Pledge reduced from Rs. 200 Cr to Rs. 60 Cr; target zero pledge in current financial year - Management confident of sustaining 30-35% revenue growth and 50% profit growth in Q3 and Q4 FY27
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 EMSLIMITED — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add EMSLIMITED to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on EMS Limited

Important. The summary above is generated automatically from EMS Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.